Chatham Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $442K | Hold |
|
|||||
|
2025
Q2 | $366K | Sell |
|
|||||
|
2025
Q1 | $403K | Sell |
|
|||||
|
2024
Q4 | $457K | Sell |
|
|||||
|
2024
Q3 | $630K | Buy |
|
|||||
|
2024
Q2 | $577K | Sell |
|
|||||
|
2024
Q1 | $599K | Hold |
|
|||||
|
2023
Q4 | $563K | Sell |
|
|||||
|
2023
Q3 | $467K | Hold |
|
|||||
|
2023
Q2 | $532K | Hold |
|
|||||
|
2023
Q1 | $488K | Sell |
|
|||||
|
2022
Q4 | $541K | Sell |
|
|||||
|
2022
Q3 | $521K | Buy |
|
|||||
|
2022
Q2 | $488K | Sell |
|
|||||
|
2022
Q1 | $607K | Sell |
|
|||||
|
2021
Q4 | $1.08M | Sell |
|
|||||
|
2021
Q3 | $1.24M | Sell |
|
|||||
|
2021
Q2 | $1.35M | Buy |
|
|||||
|
2021
Q1 | $1.35M | Buy |
|
|||||
|
2020
Q4 | $1.4M | Buy |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $1.09M | Buy |
|
|||||
|
2020
Q1 | $725K | Sell |
|
|||||
|
2019
Q4 | $5.15M | Sell |
|
|||||
|
2019
Q3 | $4.56M | Sell |
|
|||||
|
2019
Q2 | $5.42M | Buy |
|
|||||
|
2019
Q1 | $5.53M | Sell |
|
|||||
|
2018
Q4 | $4.55M | Sell |
|
|||||
|
2018
Q3 | $7.04M | Buy |
|
|||||
|
2018
Q2 | $6.86M | Hold |
|
|||||
|
2018
Q1 | $6.32M | Buy |
|
|||||
|
2017
Q4 | $6.01M | Sell |
|
|||||
|
2017
Q3 | $6.26M | Buy |
|
|||||
|
2017
Q2 | $4.84M | Buy |
|
|||||
|
2017
Q1 | $4.24M | Buy |
|
|||||
|
2016
Q4 | $3.02M | Buy |
|
|||||
|
2016
Q3 | $2.61M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $205K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $203K | Buy |
|